What is the main business of Wecares?

The main business activity of Wecares focuses on manufacture of perfumes and toilet preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 15, 2024.

Where is the headquarters located?

The headquarters is located at: Szybowcowa 8A, 80-298 Gdańsk.

Who is on the management board?

The management board includes Łukasz Piotr Janus (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 6,250 (approx. $1,688).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $131,081, representing an increase of 128.9% compared to 2024.

Is the company profitable?

No, the company recorded a net loss of $28,351 in 2025. For comparison, in 2024 the loss was $26,019, meaning the company increased its loss by 8.7%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $88,214 in 2025, representing 56% of all operating expenses.

Wecaressp. z o.o.

Manufacture of perfumes and toilet preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-07-15

Share capital

6 250,00 PLN

Registered address

Szybowcowa 8A, 80-298 Gdańsk, Poland

Electronic delivery address

AE:PL-40083-17041-DHVDG-32

Financials

Revenue history (in k)

Filing timeliness

1 of 2 financial statements was filed late (for 2024, 7 days late).

202515/07/2026
202422/07/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 131.08kMedianUSD 178.92kAverageUSD 6.85m

Net profit

This companyUSD -28.35kMedianUSD 2.73kAverageUSD 464.86k

Operating costs

This companyUSD 158.50kMedianUSD 175.18kAverageUSD 6.09m

Assets

This companyUSD 31.35kMedianUSD 160.35kAverageUSD 5.64m

Industry

Authorized Representatives

Paweł Jerzy Jankowski – Management Board Member

Łukasz Piotr Janus – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board is authorised to submit declarations of will on behalf of the company independently. In the case of a multi-member management board, the President of the Management Board is authorised to submit declarations of will independently, or two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Marta Bartkowiakage 44	50	$675.31	40%
Paweł Jerzy Jankowskiage 39	25	$337.66	20%
Łukasz Piotr Janusage 43	50	$675.31	40%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-07-19.

ING Bank Śląski
56 1050 1764 1000 0090 8385 9703

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Oceanicsp. z o.o.	$82,901,772.15	oceanic.com.pl
Nitorasp. z o.o.	$1,601,259.44	nitoralab.com
Farmacia Verdesp. z o.o. + limited partnership	$898,115.71	farmaciaverde.pl
Farmacia Verdesp. z o.o.	$41,891.92	farmaciaverde.pl
Kovalitesp. z o.o.	$21,161.45	kovalite.com
Innoplexsp. z o.o.	$11,707.96	innoplex.global
Nucadeasp. z o.o.	$297.62	nucadea.com
Herbiopharmsp. z o.o.	$0.00	herbiopharm.pl
Loton Cosmeticssp. z o.o.	–	loton.pl
Luminalabsp. z o.o.	–	bioclinical.us

FAQ

Last updated: 2026-07-15